ClinicalTrials.gg
RecruitingNCT07908238MILQ premUpdated Nov 2, 2026

Maximising Maternal Milk for Preterm Infant

An interventional study of Hospital grade double electrical breast milk pump in Breastfeeding and Prematurity, sponsored by National Maternity Hospital, Ireland. Recruiting at 3 sites in Ireland. Open to female participants. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by National Maternity Hospital, Ireland · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Nov 2025; still recruiting 1 year later.
Updated Nov 2, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Sex
Female
01

Study summary

Maternal milk is the gold standard in infant nutrition, providing significant advantages, in preterm and term infants. Maternal milk plays a major role in reducing the risk of inflammatory bowel disease(NEC) in premature and low birth weight infants as well as improving neurodevelopmental outcomes in this population, In this study the investigators are comparing earlier (from birth rather than 48 hours post delivery) use of an electrical breast pump. Mothers will be selected at random to be in one of two groups: early or later pump use. The investigators will compare milk volumes achieved on day 14 post delivery between the two groups. The investigators will recruit x number of mothers of preterm infants \< 33 weeks gestation at birth

Read the detailed description

Evidence suggests that the first two weeks after premature delivery are a critical period for initiation and development of lactation. The process is made more complicated following preterm delivery due to immaturity of mammary glands and absence of sucking by premature infants . Preterm delivery also leads to increased levels of stress and anxiety about breast milk expression, especially during the first days after delivery . All these factors can contribute to low milk volumes and reduced nutritional substrate for babies. Inadequate breast milk production during the first few days after delivery leads to longer duration of parenteral nutrition and increased use of donor milk Donor milk is less effective nutritionally and an expensive resource. In babies where donor milk provides sup optimal nutrition, formula milk is required, and this significantly increases the risk of inflammatory bowel disease in preterm infants Suboptimal milk supply is also associated with prolonged use of central lines, greater rates of sepsis and chronic lung disease and prolongation of hospital stay.

International guidelines for production of expressed breast milk (EBM) for premature infants under 34 weeks' gestation from tertiary-level hospitals in Canada, Australia, and the United Kingdom suggest starting with hand expression of milk ideally within the first 1- 3 hours as a gold standard and if that is not possible within the first six hours after delivery, they recommend switching to a double electrical breast pump after the first 24-48 hours post-delivery. Use of hand expression in the first instance is based on the small volumes of colostrum which are likely to be collected. There is no evidence to say whether hand or electrical pump expression from birth is more effective. Hand expression for seven days from birth has been shown to be less effective than pump expression over the same time period but there have been no published studies to compare hand expression as per international guidelines for 2 days followed by use of the electric pump, to use of electric pump from birth .

Currently in our neonatal unit , the recommendation that mothers start expressing breast milk early after delivery initially expressing by hand and then changing to the electric pump from 48 hours. Earlier use of the electric pump may be more effective than hand expression. In this study, the investigators would like to compare use of the electrical pump on on day 1 rather than waiting for 48 hours and compare milk output by 2 weeks of age in the two groups.

Participants will be randomly assigned to one of these two groups:

  • Group A: Mothers will hand-express milk for the first two days post-delivery, followed by the use of a hospital-grade electric pump from day 3.
  • Group B: Mothers will begin using a hospital-grade electric pump immediately after delivery, followed by hand expression for 10 minutes for the first two days after delivery, and then continue to use the electric pump alone.
02

Conditions studied

  • Breastfeeding
  • Prematurity

Keywords

  • expressed breast milk
  • lactation
  • premature feeding
  • coming to volume
  • early pump use
03

In context

Breast Feeding

1,081 studies on the registry are indexed under Breast Feeding; 217 are open to participants now.

This study's planned enrollment of 160 is above the median of 100 across 844 interventional studies indexed under Breast Feeding.

Browse Breast Feeding studies →

Lead sponsor

National Maternity Hospital, Ireland is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The infant/s are born at the National Maternity Hospital with a gestational age at birth \< 33 weeks by best obstetric estimate or with a birth weight of \< 1500g; or
  • The infant/s are born in another centre with a gestational age at birth \< 33 weeks by best obstetric estimate and/or with a birth weight of \< 1500g and the mother is admitted to the National Maternity Hospital within 24 hours of delivery

Exclusion criteria

Exclusion Criteria:

  • Breast milk use in the infant is
  • There is breast hypoplasia on examination or recent breast surgery affecting ability to produce adequate breast milk
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
160 participants (estimated)

Study arms

  • Active comparator
    Early expression group

    INTERVENTION: Mothers assigned to the early pump group will be advised to start pumping using a hospital-grade double electrical breast pump as soon after birth (target will be within first 6 hours after delivery) followed by hand expression for 10 minutes. This will occur for the first 48 hours after delivery and then mothers will start using a hospital -grade double electrical breast pump without additional hand expression.

    Device: Hospital grade double electrical breast milk pump

  • Other
    Late expression group

    CONTROL: Late pumping group: Mothers assigned to the late pumping group will be advised to start hand expression for the first 48 hours postpartum, and then start using a hospital-grade double electrical breast pump, as per routine practice.

    Device: Hospital grade double electrical breast milk pump

Interventions

  • DeviceHospital grade double electrical breast milk pump

    Mothers assigned to the early pump group will be advised to start pumping using a hospital-grade double electrical breast pump as soon after birth(target within first 6 hours after delivery) follow by hand expression for 10 minutes for the first 48 hours then start using a hospital -grade double electrical breast pump.

    Also known as: Breast pump, Electrical breast pump, Hospital grade electrical pump

06

What researchers measure

Primary outcomes

  1. Percentage of women achieving > 500mls expressed breast milk by 14 days' post-partum

    Time frame: from enrolment to two weeks post delivery

  2. Percentage of women achieving > 500mls by 14 days' post-partum in mothers of preterm infants < 33 weeks gestation and/or 1500 gram

    Mothers of preterm infants \<33 weeks and /or 1500 gram will randomly assigned to early breast pumping group or late breast pumping group as outlined above , the primary outcome is the achieving of more than 500 ml of breast milk by day 14 post delivery.

    Time frame: Milk amount from time of enrolment to two weeks post delivery

Secondary outcomes

  1. Parenteral nutrition days

    Total days of parenteral nutrition until reaching to full feed

    Time frame: From the time of enrolment until 6 weeks post menstrual age

  2. Time to full feeds

    How many days required to reach full feed

    Time frame: From date of randomization until reaching fullfeed

  3. Donor milk use

    The number of participants who required donor milk from birth until discharge

    Time frame: From the time of enrolment until 6 weeks post menstrual age

  4. Central line associated blood stream infections

    The number of participants with any documented central line infection from birth until discharge from hospital .Catheter-related bloodstream infection Clinical signs of sepsis and positive peripheral blood culture in the absence of an obvious source other than CVC with one of the following: Positive semiquantitative (\>15 CFU) or quantitative (\>103 CFU) culture from a part of the catheter with the same organisms isolated peripherally Simultaneous quantitative blood cultures with a ratio of ≥3:1 (CVC vs. peripheral) Time difference of ≤2 hours leading to culture positive between CVC and peripheral cultures. Central line-associated bloodstream infection is primary bloodstream infection in a patient who had a central line within the 48 hours period before development of infection.

    Time frame: From the time of enrolment until 6 weeks post menstrual age

  5. Necrotising enterocolitis

    The number of participants who had any episode of necrotizing enterocolitis as defined by Modified Bell's staging criteria from enrolment to discharge.

    Time frame: From the time of enrolment until 6 weeks post menstrual age

  6. Chronic lung disease

    Total numbers of days of respiratory support for the participant

    Time frame: From the time of enrolment until 6 weeks post menstrual age

  7. Late onset sepsis

    The number of participants who had any documented late onset sepsis, described as documented infection after 72 hours after birth .

    Time frame: From the time of enrolment until 6 weeks post menstrual age

  8. Breastfeeding at hospital discharge

    The number of participants involved in the study discharged home on breast feeding

    Time frame: From the time of enrolment until 6 weeks post menstrual age

  9. Death before hospital discharge

    The number of participants ,time and cause of death during the study period

    Time frame: From birth to time and date of death

  10. Duration of hospitalisation

    To duration in days of hospital stay from birth until discharge from hospital

    Time frame: From date of randomization until the date of discharge home

  11. Parental attitudes and experiences (interviews with parents to access and enhance family centre care model)

    During study period , we are going to carry out interview with parents on level of education during antenatal period on the use of hospital breast pumping , when and how to access breast pumping device , pain associated with hand expression and breast pumping device . Level of education and support during first weeks after delivery . Added more , we are going to perform eduction sessions to the postnatal and delivery wards staff , NICU staff including Consultants , junior doctors and nursing staff .

    Time frame: From time of birth to discharge from hospital

  12. Formula milk

    The number of participants who used of formula milk at any stage after birth until discharge from hospital

    Time frame: From the time of enrolment until 6 weeks post menstrual age

07

Study locations

1 of 3 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — IPD may be shared following publication following reasonable ethically approved request

Time frame: 24 months

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07908238
Lead sponsor
National Maternity Hospital, Ireland
Responsible party
Sarah Kasha (Consultant Neonatology, National Maternity Hospital, Ireland) — Principal investigator
First posted
Nov 2, 2026
Start date
Nov 7, 2025
Primary completion
Jul 1, 2027 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Nov 2, 2026

Study contacts

Anna Curley, Consultant Neonatologist
Contact
anna.curley@nmh.ie
003531637300
Sarah Kasha, Consultant Neonatology
Contact
sarah.kasha@nmh.ie
00353876111218
Anna Curley, Consultant Neonatology
principal investigator · National Maternity Hospital
Madeleine Murphy, Consultant Neonatology
principal investigator · National Maternity Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion